(R)- and (S)-[11C]verapamil as PET-tracers for measuring P-glycoprotein function: in vitro and in vivo evaluation
- 11 September 2003
- journal article
- research article
- Published by Elsevier in Nuclear Medicine and Biology
- Vol. 30 (7) , 747-751
- https://doi.org/10.1016/s0969-8051(03)00078-7
Abstract
No abstract availableKeywords
This publication has 26 references indexed in Scilit:
- Fully automated high yield synthesis of (R)‐ and (S)‐[11C]verapamil for measuring P‐glycoprotein function with positron emission tomographyJournal of Labelled Compounds and Radiopharmaceuticals, 2002
- Deposition of Alzheimer's ??-amyloid is inversely correlated with P-glycoprotein expression in the brains of elderly non-demented humansPharmacogenetics, 2002
- Synthesis and evaluation of radiolabeled antagonists for imaging of β-adrenoceptors in the brain with PETNeurochemistry International, 2002
- Considerations in the Use of Cerebrospinal Fluid Pharmacokinetics to Predict Brain Target Concentrations in the Clinical SettingClinical Pharmacokinetics, 2002
- The Impact of Efflux Transporters in the Brain on the Development of Drugs for CNS DisordersClinical Pharmacokinetics, 2002
- β‐Amyloid efflux mediated by p‐glycoproteinJournal of Neurochemistry, 2001
- Complete in vivo reversal of P‐glycoprotein pump function in the blood‐brain barrier visualized with positron emission tomographyBritish Journal of Pharmacology, 1998
- P-glycoprotein in the blood-brain barrier of mice influences the brain penetration and pharmacological activity of many drugs.Journal of Clinical Investigation, 1996
- Disruption of the mouse mdr1a P-glycoprotein gene leads to a deficiency in the blood-brain barrier and to increased sensitivity to drugsPublished by Elsevier ,1994
- Pharmacokinetics and biodistribution of a new anti-episialin monoclonal antibody 139H2 in ovarian-cancer-bearing nude miceCancer Immunology, Immunotherapy, 1991